CTI BIOPHARMA CORP (CTIC) 5.52 -0.11 (-1.95%)
5.52 -0.11 (-1.95%)
US12648L6011 - Common Stock - After market: 5.54 +0.02 (+0.36%)
CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that senior leadership will participate in a Fireside Chat at the following investor...
CTI BioPharma Breaks Below 200-Day Moving Average - Notable for CTIC
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
Noteworthy Wednesday Option Activity: OSPN, RKT, CTIC
CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will present a corporate overview at the 41st Annual J.P. Morgan Healthcare...
CTIC Crosses Below Key Moving Average Level
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at...
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope
/PRNewswire/ -- The global ovarian cancer market is projected to continue to grow through the coming several years. The formation of mutational cells or...
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope
EQNX::TICKER_START (OTCQB:BVAXF),(NASDAQ:CTIC),(NASDAQ:SGEN),(NYSE:MRK),(NASDAQ:IMGN) EQNX::TICKER_END
CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will participate in a fireside chat at the JMP Securities Hematology and...
Interesting CTIC Put And Call Options For January 2023
CTI BioPharma to Present at Upcoming November Conferences
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at two upcoming investor conferences in...
CTI BioPharma Reports Third Quarter 2022 Financial Results
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the third quarter ended September 30, 2022....
CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022
/PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2022 financial results on...
Interesting CTIC Put And Call Options For June 2023
Why CTI BioPharma Stock Crushed the Market Today
Simultaneous double thumbs-ups from a pair of pundits gave it boost.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
Why CTI BioPharma Stock Withered on Wednesday
Investors didn't exactly cheer the latest prognosticator move on the company's shares.